Christophe R. Jean

Mr. Jean has served as a member of our Board of Directors since April 2015. He is a seasoned global pharmaceutical industry executive, having held leadership positions in strategy, finance, business development, M&A and alliances, and managing international operations. He recently retired from Ipsen in July 2018, where he was Executive Vice President for Corporate Strategy, Business Development, and Strategic Alliances, a position he assumed in 2013 after serving for 11 years in the position of Executive Vice President, Chief Operating Officer, with responsibility for all commercial operations and medical affairs worldwide as well as Ipsen’s therapeutic area franchises. Prior to joining Ipsen, Mr. Jean was President and CEO for the pharmaceutical activities of the Pierre Fabre Group and President of Europe, Middle East, and Africa for Novartis’ Pharmaceutical Division. Prior to the merger of Ciba-Geigy and Sandoz that formed Novartis, he held a number of marketing and management positions in Europe and Latin America for Ciba-Geigy, culminating as Head of Finance and IT Worldwide and Member of the Pharma Executive Committee. Mr. Jean is a Senior Advisor of JSB Partners, a boutique firm providing advisory services to the pharmaceutical industry, and he presently is a board member of Keosys and B-Cell-Design in France. He holds an MBA from Harvard Business School.